Immune Checkpoint Inhibitors in Head and Neck Cancer: Understanding the Current Evidence and Future Directions

Download slidesets and review an archived webcast from a live symposium in which 3 experts discussed the rationale for checkpoint inhibition in advanced HNSCC, provided practical guidance on clinical use, and assessed promising near-future immunotherapies for HNSCC. Review key points for HNSCC treatment with a downloadable resource guide.

Barbara Burtness, MD
Program Director


Review key points for using immune checkpoint inhibitors for HNSCC treatment with this downloadable resource guide.

Barbara Burtness, MD
Program Director
Released: June 25, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?